Sugi Pharmacy, officially known as Sugi Holdings Co., Ltd., is a prominent player in the Japanese pharmaceutical industry, headquartered in Japan. Established in 1976, the company has grown significantly, operating over 1,000 pharmacies across major regions, including Kanto and Kansai. Specialising in prescription medications, over-the-counter drugs, and health-related products, Sugi Pharmacy distinguishes itself through its commitment to customer service and community health. The company has achieved notable milestones, including the introduction of innovative health management services that cater to the evolving needs of its clientele. With a strong market position, Sugi Pharmacy is recognised for its extensive product range and dedication to enhancing the well-being of its customers, making it a trusted name in the healthcare sector.
How does Sugi Pharmacy's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sugi Pharmacy's score of 10 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Sugi Pharmacy reported significant carbon emissions, with a total of approximately 1,715,396,000 kg CO2e attributed to Scope 3 emissions. This figure includes various categories such as purchased goods and services (about 1,601,452,000 kg CO2e) and upstream transportation and distribution (approximately 1,252,000 kg CO2e). The company has also disclosed emissions for previous years, showing a trend in their carbon footprint. For instance, in 2021, Sugi Pharmacy's total emissions were about 1,521,490,000 kg CO2e, with Scope 1 emissions at approximately 1,299,000 kg CO2e and Scope 2 emissions at about 18,191,000 kg CO2e. The data indicates a focus on understanding and managing their emissions, particularly in Scope 3, which often represents the largest share of a company's carbon footprint. Despite the detailed emissions reporting, Sugi Pharmacy has not set specific reduction targets or climate pledges, indicating a potential area for improvement in their sustainability strategy. The absence of formal commitments suggests that while the company is tracking its emissions, it may not yet be actively pursuing aggressive reduction initiatives. Overall, Sugi Pharmacy's emissions data highlights the importance of addressing Scope 3 emissions and the need for clear climate commitments to enhance their sustainability efforts in the pharmaceutical retail sector.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|
Scope 1 | 107,000 | 00,000 | 0,000,000 | - |
Scope 2 | 4,140,000 | 0,000,000 | 00,000,000 | - |
Scope 3 | 2,760,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sugi Pharmacy is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.